Supplements

Nothing here is approved for MCAS, and almost nothing has been tested in it. Every entry borrows its evidence from somewhere else. What differs is where from. Where no clinical sequence sets an order, an internal rank uses the strongest cited study design that directly involved mast cells. That affects browsing order only, not clinical importance. Each card shows the relationship and study types directly, plus any conditions actually approved or trialled.

8 entries. No dosing, and no claim that anything here works. How this is decided.

Outside that sequence — not part of the stepwise approach the review describes